GKB Ophthalmics Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Krishna Gupta

Algemeen directeur

₹4.7m

Totale compensatie

Percentage CEO-salaris	76.0%
Dienstverband CEO	42.9yrs
Eigendom CEO	29.6%
Management gemiddelde ambtstermijn	geen gegevens
Gemiddelde ambtstermijn bestuur	1.4yrs

Recente managementupdates

Recent updates

Analyse CEO-vergoeding

Hoe is Krishna Gupta's beloning veranderd ten opzichte van GKB Ophthalmics's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	-₹36m
Jun 30 2024	n/a	n/a	-₹36m
Mar 31 2024	₹5m	₹4m	-₹28m
Dec 31 2023	n/a	n/a	-₹38m
Sep 30 2023	n/a	n/a	-₹36m
Jun 30 2023	n/a	n/a	-₹16m
Mar 31 2023	₹5m	₹4m	-₹2m
Dec 31 2022	n/a	n/a	₹24m
Sep 30 2022	n/a	n/a	₹43m
Jun 30 2022	n/a	n/a	₹31m
Mar 31 2022	₹5m	₹4m	₹13m
Dec 31 2021	n/a	n/a	₹17m
Sep 30 2021	n/a	n/a	₹10m
Jun 30 2021	n/a	n/a	₹11m
Mar 31 2021	₹4m	₹3m	-₹9m
Dec 31 2020	n/a	n/a	-₹21m
Sep 30 2020	n/a	n/a	-₹22m
Jun 30 2020	n/a	n/a	-₹32m
Mar 31 2020	₹4m	₹3m	-₹18m
Dec 31 2019	n/a	n/a	-₹3m
Sep 30 2019	n/a	n/a	-₹23m
Jun 30 2019	n/a	n/a	-₹14m
Mar 31 2019	₹4m	₹3m	-₹11m
Mar 31 2018	₹4m	₹3m	-₹10m

Compensatie versus markt: De totale vergoeding ($USD 56.21K ) Krishna } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de Indian markt ($USD 42.72K ).

Compensatie versus inkomsten: De vergoeding van Krishna is gestegen terwijl het bedrijf verliesgevend is.

CEO

Krishna Gupta (84 yo)

42.9yrs

Tenure

₹4,737,029

Compensatie

Mr. Krishna Gopal Gupta serves as the Chairman and Managing Director at GKB Ophthalmic Limited serves as its Director since December 10, 1981. Mr. Gupta serves as Chairman of Prime Lenses Pvt. Ltd.He has...

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Krishna Gupta	Chairman & MD	42.9yrs	₹4.74m	29.65% ₹ 143.5m
Cedric Lobo	Senior Manager of HR & Administration and Non Independent	less than a year	geen gegevens	geen gegevens
Vikram Gupta	Non-Executive Director	28.3yrs	₹30.00k	8.39% ₹ 40.6m
Shashi Katreddi	Independent Non-Executive Director	9.7yrs	₹110.00k	geen gegevens
Ninad Kamat	Independent & Non Executive Director	less than a year	geen gegevens	geen gegevens
Purushottam Mantri	Independent & Non-Executive Director	1.4yrs	₹120.00k	geen gegevens
Sandhya Kamat	Additional Independent & Non-Executive Director	less than a year	geen gegevens	geen gegevens

1.4yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van 533212 wordt niet als ervaren beschouwd (gemiddelde ambtstermijn 1.4 jaar), wat duidt op een nieuw bestuur.

GKB Ophthalmics Beheer

Beheer criteriumcontroles 0/4

Belangrijke informatie

Recente managementupdates

GKB Ophthalmics Limited, Annual General Meeting, Aug 20, 2024

GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director

GKB Ophthalmics Limited, Annual General Meeting, Sep 14, 2023

Insufficient new directors

Insufficient new directors

Insufficient new directors

Recent updates

Second quarter 2025 earnings released: ₹2.41 loss per share (vs ₹2.32 loss in 2Q 2024)

GKB Ophthalmics Limited to Report Q2, 2025 Results on Nov 14, 2024

First quarter 2025 earnings released: ₹0.50 loss per share (vs ₹1.04 profit in 1Q 2024)

GKB Ophthalmics Limited to Report Q1, 2025 Results on Aug 13, 2024

Full year 2024 earnings released: ₹5.58 loss per share (vs ₹0.33 loss in FY 2023)

GKB Ophthalmics Limited, Annual General Meeting, Aug 20, 2024

GKB Ophthalmics Limited to Report Q4, 2024 Results on May 30, 2024

New minor risk - Share price stability

GKB Ophthalmics Limited Announces Resignation of Subhash Redkar as Executive Director / Whole Time Director

Third quarter 2024 earnings released: ₹2.48 loss per share (vs ₹2.05 loss in 3Q 2023)

GKB Ophthalmics Limited to Report Q3, 2024 Results on Feb 14, 2024

Second quarter 2024 earnings released: ₹2.32 loss per share (vs ₹1.68 profit in 2Q 2023)

First quarter 2024 earnings released: EPS: ₹1.04 (vs ₹3.84 in 1Q 2023)

Full year 2023 earnings released: ₹0.33 loss per share (vs ₹2.53 profit in FY 2022)

GKB Ophthalmics Limited, Annual General Meeting, Sep 14, 2023

Investor sentiment improves as stock rises 16%

GKB Ophthalmics Limited to Report Q4, 2023 Results on May 30, 2023

Investor sentiment improves as stock rises 16%

Investor sentiment deteriorates as stock falls 22%

Third quarter 2023 earnings released: ₹2.05 loss per share (vs ₹1.63 profit in 3Q 2022)

Investor sentiment improves as stock rises 20%

Investor sentiment improved over the past week

Second quarter 2023 earnings released: EPS: ₹1.68 (vs ₹0.67 loss in 2Q 2022)

Insufficient new directors

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Insufficient new directors

Investor sentiment improved over the past week

First quarter 2023 earnings released: EPS: ₹3.84 (vs ₹0.27 in 1Q 2022)

GKB Ophthalmics Limited to Report Q1, 2023 Results on Aug 12, 2022

Investor sentiment improved over the past week

GKB Ophthalmics Limited to Report Q4, 2022 Results on May 30, 2022

Insufficient new directors

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment improved over the past week

Insufficient new directors

First quarter 2022 earnings released: EPS ₹0.27 (vs ₹3.68 loss in 1Q 2021)

Full year 2021 earnings released: ₹1.80 loss per share (vs ₹3.65 loss in FY 2020)

GKB Ophthalmics Limited to Report Q3, 2021 Results on Feb 10, 2021

New 90-day high: ₹60.00

New 90-day low: ₹47.25

First quarter earnings released

Full year earnings released - ₹3.65 loss per share

GKB Ophthalmics Limited to Report Q1, 2021 Results on Aug 19, 2020

New 90-day low - ₹52.65

GKB Ophthalmics Limited to Report Q2, 2020 Results on Sep 07, 2020

New 90-day low - ₹55.25

Analyse CEO-vergoeding

CEO

Tenure

Compensatie

Bestuursleden

Gemiddelde duur

Gemiddelde leeftijd